WebRTC Solutions Industry News

TMCNet:  U.S. Patents Awarded to Inventors in California (March 20)

[March 20, 2011]

U.S. Patents Awarded to Inventors in California (March 20)

(Targeted News Service Via Acquire Media NewsEdge) Targeted News Service Targeted News Service ALEXANDRIA, Va., March 20 -- The following federal patents were awarded to inventors in California.

*** Alpha and Omega Semiconductor Assigned Patent ALEXANDRIA, Va., March 20 -- Alpha and Omega Semiconductor, Sunnyvale, Calif., has been assigned a patent (7,897,438) developed by four co-inventors for a "method of making semiconductor package with plated connection." The co-inventors are Leeshawn Luo, Santa Clara, Calif., Kai Liu, Sunnyvale, Calif., Ming Sun, Sunnyvale, Calif., and Xiao Tian Zhang, San Jose, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A semiconductor package and method for making a semiconductor package are disclosed. The semiconductor package has a top surface and a mounting surface and includes a die, a conducting connecting material, a plating material and an insulating material. The die has a processed surface facing towards the mounting surface of the semiconductor package. Exposed metal connections are at the processed surface of the die. The conducting connecting material is disposed on the exposed metal connections. The plating material is in contact with the conducting connecting material. The insulating material is formed around the conducting connecting material, and the plating material extends to the exterior of the insulating material." The patent application was filed on May 22, 2008 (12/154,537). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=461&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=10&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** Ceres Assigned Patent for Methods for Modifying Plant Characteristics ALEXANDRIA, Va., March 20 -- Ceres, Thousand Oaks, Calif., has been assigned a patent (7,897,839) developed by Roger I. Pennell, Malibu, Calif., Chuan-Yin Wu, Newbury Park, Calif., and Hongyu Zhang, Los Angeles, for "methods for modifying plant characteristics." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Isolated polynucleotides, polypeptides, and transgenic plants are described. The transgenic plants can exhibit one or more altered phenotypic characteristics relative to a control plant, including increased height, increased seed weight, increased photosynthetic rates, decreased levels of campestanol, or increased levels of 6-deoxocathasterone." The patent application was filed on April 22, 2005 (11/112,824). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=422&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=9&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** Hexcel Assigned Patent ALEXANDRIA, Va., March 20 -- Hexcel, Dublin, Calif., has been assigned a patent (7,897,703) developed by Yen-Seine Wang, Dublin, Calif., for an "epoxy resin and 4,4'-diaminobenzanilide powder." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Epoxy resin compositions that include an epoxy resin component and a curative powder comprising particles of 4,4'-diaminobenzanilide (DABA) wherein the size of the DABA particles is less than 100 microns and wherein the median particle size is below 20 microns." The patent application was filed on May 20, 2009 (12/468,926). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=433&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=9&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** Ardea Biosciences Assigned Patent for Pyridone Sulfonamides and Pyridone Sulfamides as MEK Inhibitors ALEXANDRIA, Va., March 20 -- Ardea Biosciences, San Diego, has been assigned a patent (7,897,624) developed by five co-inventors for a "pyridone sulfonamides and pyridone sulfamides as MEK inhibitors." The co-inventors are Shunqi Yan, Irvine, Calif., Jean-Michel Vernier, Laguna Niguel, Calif., Zhi Hong, Irvine, Calif., Suetying Chow, Irvine, Calif., and Yung-hyo Koh, Irvine, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "This invention concerns N-(ortho phenylamino dihydropyridyl)sulfonamides and N-(ortho phenylamino dihydropyridyl), N'-alkyl sulfamides which are inhibitors of MEK and are useful in the treatment of cancer and other hyperproliferative diseases." The patent application was filed on April 18, 2007 (11/737,109). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=438&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=9&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** Palo Alto Research Center Assigned Patent ALEXANDRIA, Va., March 20 -- Palo Alto Research Center, Palo Alto, Calif., has been assigned a patent (7,897,439) developed by Robert A. Street, Palo Alto, Calif., and Ana Claudia Arias, San Carlos, Calif., for an "electronic device with unique encoding." The abstract of the patent published by the U.S. Patent and Trademark Office states: "An electronic device comprising a thin film transistor (TFT) array and manufacturing methods thereof according to various embodiments. Jet-printed material is deposited on selected partially formed transistors to form completed transistors. Thus, a selected number of the TFTs are connected into the circuit while the remainder of the TFTs are not connected. An electronic read-out of the array identifies the specific array by distinguishing the connected TFTs from the unconnected ones. For a TFT array with n elements there are 2.sup.n alternative configurations; therefore, a relatively small number of TFTs can uniquely identify a huge number of devices. Such uniquely encoded devices have applications for encryption, identification and personalization of electronic systems." The patent application was filed on Dec. 23, 2009 (12/645,987). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=460&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=10&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** Mendel Biotechnology Assigned Patent ALEXANDRIA, Va., March 20 -- Mendel Biotechnology, Hayward, Calif., has been assigned a patent (7,897,843) developed by 15 co-inventors for a "transcriptional regulation of plant biomass and abiotic stress tolerance." The co-inventors are Cai-Zhong Jiang, Fremont, Calif., Jacqueline E. Heard, Stonington, Conn., Oliver Ratcliffe, Oakland, Calif., Neal I. Gutterson, Oakland, Calif., Frederick D. Hempel, Albany, Calif., Roderick W. Kumimoto, San Bruno, Calif., James S. Keddie, San Mateo, Calif., Bradley K. Sherman, Berkeley, Calif., Jeffrey M. Libby, Cupertino, Calif., Jindong Sun, Urbana, Ill., Kimberly Faye Zobrist-Duff, Greenville, Ill., Jingrui Wu, Chesterfield, Mo., Changlin Fu, Chesterfield, Mo., Stanton B. Dotson, Chesterfield, Mo., and Linda L. Lutfiyya, St. Louis.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention relates to plant transcription factor polypeptides, polynucleotides that encode them, homologs from a variety of plant species, and methods of using the polynucleotides and polypeptides to produce transgenic plants having advantageous properties, including increased biomass or improved cold or other osmotic stress tolerance, as compared to wild-type or reference plants. The invention also pertains to expression systems that may be used to regulate these transcription factor polynucleotides, providing constitutive, transient, inducible and tissue-specific regulation." The patent application was filed on June 16, 2004 (10/870,198). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=421&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=9&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** Althea Technologies Assigned Patent for Strategies for Gene Expression Analysis ALEXANDRIA, Va., March 20 -- Althea Technologies, San Diego, has been assigned a patent (7,897,750) developed by Joseph Monforte, Kensington, Calif., for "strategies for gene expression analysis." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention provides methods for screening compound or chemical libraries by analyzing expressed RNA samples from biological samples treated with members of a compound library in a high throughput format." The patent application was filed on Nov. 26, 2008 (12/315,115). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=428&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=9&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** Isis Pharmaceuticals Assigned Patent ALEXANDRIA, Va., March 20 -- Isis Pharmaceuticals, Carlsbad, Calif., has been assigned a patent (7,897,583) developed by five co-inventors for "compositions and their uses directed to PTPRU." The co-inventors are Robert McKay, Poway, Calif., Ravi Jain, Carlsbad, Calif., Kenneth W. Dobie, Del Mar, Calif., Sanjay K. Pandey, Encinitas, Calif., and Sanjay Bhanot, Carlsbad, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Disclosed herein are compounds, compositions and methods for modulating the expression of PTPRU in a cell, tissue or animal. Also provided are methods of active target segment validation. Also provided are uses of disclosed compounds and compositions in the manufacture of a medicament for treatment of diseases and disorders. Also provided are methods for the prevention, amelioration and/or treatment of diabetes, obesity, insulin resistance, insulin deficiency, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hyperfattyacidemia, liver steatosis, steatohepatitis, non-alcoholic steatohepatitis, metabolic syndrome, cardiovascular disease and coronary heart disease by administration of antisense compounds targeted to PTPRU." The patent application was filed on May 24, 2006 (11/915,309). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=443&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=9&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** Synopsys Assigned Patent ALEXANDRIA, Va., March 20 -- Synopsys, Mountain View, Calif., has been assigned a patent (7,897,479) developed by Xi-Wei Lin, Fremont, Calif., Dipankar Pramanik, Saratoga, Calif., and Victor Moroz, Saratoga, Calif., for a "managing integrated circuit stress using dummy diffusion regions." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Roughly described, methods and systems for improving integrated circuit layouts and fabrication processes in order to better account for stress effects. Dummy features can be added to a layout either in order to improve uniformity, or to relax known undesirable stress, or to introduce known desirable stress. The dummy features can include dummy diffusion regions added to relax stress, and dummy trenches added either to relax or enhance stress. A trench can relax stress by filling it with a stress-neutral material or a tensile strained material. A trench can increase stress by filling it with a compressive strained material. Preferably dummy diffusion regions and stress relaxation trenches are disposed longitudinally to at least the channel regions of N-channel transistors, and transversely to at least the channel regions of both N-channel and P-channel transistors. Preferably stress enhancement trenches are disposed longitudinally to at least the channel regions of P-channel transistors." The patent application was filed on Sept. 9, 2008 (12/207,349). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=455&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=10&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** University of California Assigned Patent for Control of Fruit Dehiscence in Plants by Indehiscent1 Genes ALEXANDRIA, Va., March 20 -- The University of California, Oakland, Calif., has been assigned a patent (7,897,848) developed by Martin F. Yanofsky, San Diego, and Sarah Liljegren, La Jolla, Calif., for a "control of fruit dehiscence in plants by indehiscent1 genes." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present application provides methods and compositions that modulate fruit dehiscence in plants." The patent application was filed on Nov. 6, 2006 (11/594,053). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=420&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=9&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** Agensys Assigned Patent ALEXANDRIA, Va., March 20 -- Agensys, Santa Monica, Calif., has been assigned a patent (7,897,740) developed by six co-inventors for a "secreted protein called 36P6D5 characteristic of tumors." The co-inventors are Arthur B. Raitano, Los Angeles, Aya Jakobovits, Beverly Hills, Calif, Mary Faris, Los Angeles, Daniel E. H. Afar, Fremont, Calif., Rene S. Hubert, Los Angeles, and Steve Chappell Mitchell, Gurnee, Ill.

The abstract of the patent published by the U.S. Patent and Trademark Office states: " Described is a gene and its encoded secreted tumor antigen, termed 36P6D5, and to diagnostic and therapeutic methods and compositions useful in the management of various cancers which express 36P6D5, particularly including cancers of the bladder, kidney, prostate, breast, colon, ovary, and pancreas." The patent application was filed on Feb. 26, 2009 (12/393,936). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=431&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=9&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** Allergan Assigned Patent ALEXANDRIA, Va., March 20 -- Allergan, Irvine, Calif., has been assigned a patent (7,897,629) developed by Robert M. Burk, Laguna Beach, Calif., David W. Old, Irvine, Calif., and Todd S. Gac, Irvine, Calif., for therapeutic compounds.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Disclosed herein is a compound having a structure ##STR00001## or a pharmaceutically acceptable salt thereof, or a prodrug thereof. Therapeutic methods, compositions, and medicaments related thereto are also disclosed." The patent application was filed on June 2, 2009 (12/476,467). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=437&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=9&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** Novellus Systems Assigned Patent ALEXANDRIA, Va., March 20 -- Novellus Systems, San Jose, Calif., has been assigned a patent (7,897,516) developed by Ronald L. Kinder, Oakland, Calif., and Anshu A. Pradhan, San Jose, Calif., for "use of ultra-high magnetic fields in resputter and plasma etching." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Methods for resputtering and plasma etching include an operation of generating an ultra-high density plasma using an ultra-high magnetic field. For example, a plasma density of at least about 10.sup.13 electrons/cm.sup.3 is achieved by confining a plasma using a magnetic field of at least about 1 Tesla. The ultra-high density plasma is used to create a high flux of low energy ions at the wafer surface. The formed high density low energy plasma can be used to sputter etch a diffusion barrier or a seed layer material in the presence of an exposed low-k dielectric layer. For example, a diffusion barrier material can be etched with a high etch rate to deposition rate (E/D) ratio (e.g., with E/D>2) without substantially damaging an exposed dielectric layer. Resputtering and plasma etching can be performed, for example, in iPVD and in plasma pre-clean tools, equipped with magnets configured for confining a plasma." The patent application was filed on May 24, 2007 (11/807,183). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=448&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=9&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** Innovalight Assigned Patent ALEXANDRIA, Va., March 20 -- Innovalight, Sunnyvale, Calif., has been assigned a patent (7,897,489) developed by Elena Rogojina, Los Altos, Calif., for a "selective activation of hydrogen passivated silicon and germanium surfaces." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method of selectively attaching a capping agent to an H-passivated Si or Ge surface is disclosed. The method includes providing the H-passivated Si or Ge surface, the H-passivated Si or Ge surface including a set of covalently bonded Si or Ge atoms and a set of surface substitutional atoms, wherein the set of surface substitutional atoms includes at least one of boron atoms, aluminum atoms, gallium atoms, indium atoms, tin atoms, lead atoms, phosphorus atoms, arsenic atoms, sulfur atoms, and bismuth atoms. The method also includes exposing the set of surface functional atoms to a set of capping agents, each capping agent of the set of capping agents having a set of functional groups bonded to a pair of carbon atoms, wherein the pair of carbon atoms includes at least one pi orbital bond, and further wherein a covalent bond is formed between at least some surface substitutional atoms of the set of surface substitutional atoms and at least some capping agents of the set of capping agents." The patent application was filed on June 17, 2008 (12/140,776). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=452&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=10&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** Theravance Assigned Patent ALEXANDRIA, Va., March 20 -- Theravance, South San Francisco, Calif., has been assigned a patent (7,897,775) developed by Sean M. Dalziel, San Francisco, and Kirsten M. Phizackerley, San Rafael, Calif., for a "crystalline form of a benzimidazole-carboxamide medicinal compound." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention provides crystalline forms of the novel benzimidazole-carboxamide 5-HT.sub.4 receptor agonist compound, 4-(4-{[(2-isopropyl-1H-benzoimidazole-4-carbonyl)amino]methyl}-piperidin-- 1-ylmethyl)piperidine-1-carboxylic acid methyl ester. The invention also provides pharmaceutical compositions comprising the crystalline compound, methods of using the compound to treat diseases associated with 5-HT.sub.4 receptor activity, and processes useful for preparing crystalline forms of the compound." The patent application was filed on Oct. 13, 2009 (12/578,180). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=424&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=9&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** University of California Assigned Patent for Conjugated Polymers Suitable for Strand-Specific Polynucleotide Detection ALEXANDRIA, Va., March 20 -- The University of California, Oakland, Calif., has been assigned a patent (7,897,684) developed by Guillermo C. Bazan, Santa Barbara, Calif., and Bin Liu, Singapore, for "conjugated polymers suitable for strand-specific polynucleotide detection in homogeneous and solid state assays." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention further relates to polycationic multichromophores, which may be conjugated polymers, and methods, articles and compositions employing them as described herein. In some aspects, the invention relates to methods, articles and compositions for the detection and analysis of biomolecules in a sample. Provided assays include those determining the presence of a target biomolecule in a sample or its relative amount, or the assays may be quantitative or semi-quantitative. The methods can be performed on a substrate. The methods can be performed in an array format on a substrate, which can be a sensor. In some embodiments, detection assays are provided employing sensor biomolecules that do not comprise a fluorophore that can exchange energy with the cationic multichromophore. In some aspects biological assays are provided in which energy is transferred between one or more of the multichromophore, a label on the target biomolecule, a label on the sensor biomolecule, and/or a fluorescent dye specific for a polynucleotide, in all permutations. The multichromophore may interact at least in part electrostatically with the sensor and/or the target, and an increase in energy transfer with the polymer may occur upon binding of the sensor and the target. Other variations of the inventions are described further herein." The patent application was filed on Jan. 10, 2006 (11/329,495). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=434&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=9&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** Salk Institute for Biological Studies Assigned Patent ALEXANDRIA, Va., March 20 -- Salk Institute for Biological Studies, La Jolla, Calif., has been assigned a patent (7,897,637) developed by Pamela A. Maher, La Jolla, Calif., for "methods of using flavonoids to enhance memory." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Described herein are flavonoids (e.g., 5-desoxy flavones and/or 5-desoxy flavonols, including without limitation fisetin and its derivatives) that activate ERK and induce CREB phosphorylation in neuronal cultures, facilitate long-term potentiation in hippocampal slices and enhance object recognition in vivo. Methods of using these flavonoids, for instance, for enhancing memory are described." The patent application was filed on July 19, 2007 (11/780,350). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=436&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=9&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** Cadence Design Systems Assigned Patent ALEXANDRIA, Va., March 20 -- Cadence Design Systems, San Jose, Calif., has been assigned a patent (7,897,522) developed by four co-inventors for a "method and system for improving particle beam lithography." The co-inventors are Akira Fujimura, Saratoga, Calif., James Fong, Cupertino, Calif., Takashi Mitsuhashi, Fujisawa, Japan, and Shohei Matsushita, Yokohama, Japan.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method for particle beam lithography, such as electron beam (EB) lithography, includes forming a plurality of cell patterns on a stencil mask and shaping one or more of the cell patterns with a polygonal-shaped contour. A first polygonal-shaped cell pattern is exposed to a particle beam so as to project the first polygonal-shaped cell pattern on a substrate. A second polygonal-shaped cell pattern, having a contour that mates with the contour of the first polygonal-shaped cell pattern, is exposed to the particle beam, such as an electron beam, so as to project the second polygonal-shaped cell pattern adjacent to the first polygonal-shaped cell pattern to thereby form a combined cell with the contour of the first polygonal-shaped cell pattern mated to the contour of the second polygonal-shaped cell pattern. The polygonal-shaped contour of the first and second cell patterns may comprise a rectilinear-shaped contour." The patent application was filed on Nov. 21, 2006 (11/603,603). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=447&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=9&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** Lam Research Assigned Patent ALEXANDRIA, Va., March 20 -- Lam Research, Fremont, Calif., has been assigned a patent (7,897,507) developed by Igor C. Ivanov, Dublin, Calif., for "barrier layer configurations and methods for processing microelectronic topographies having barrier layers." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A microelectronic topography includes a dielectric layer (DL) with a surface higher than an adjacent bulk metal feature (BMF) and further includes a barrier layer (BL) upon the BMF and extending higher than the DL. Another microelectronic topography includes a BL with a metal-oxide layer having a metal element concentration which is disproportionate relative to concentrations of the element within metal alloy layers on either side of the metal-oxide layer. A method includes forming a BL upon a BMF such that portions of a first DL adjacent to the BMF are exposed, selectively depositing a second DL upon the BL, cleaning the topography thereafter, and blanket depositing a third DL upon the cleaned topography. Another method includes polishing a microelectronic topography such that a metallization layer is coplanar with a DL and further includes spraying a deionized water based fluid upon the polished topography to remove debris from the DL." The patent application was filed on March 8, 2010 (12/719,167). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=450&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=9&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** University of California Assigned Patent for Purifications of Pomegranate Ellagitannins and Their Uses ALEXANDRIA, Va., March 20 -- The University of California, Oakland, Calif., has been assigned a patent (7,897,791) developed by Navindra P. Seeram, Kingston, R.I., and David Heber, Los Angeles, for "purifications of pomegranate ellagitannins and their uses thereof." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Compositions of purified and biologically active ellagitannins are provided by separation from pomegranate husk using a method of extraction and purification using a solid polymeric adsorbent and the uses of the said compounds." The patent application was filed on Dec. 24, 2009 (12/647,229). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=423&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=9&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** Applied Biosystems Assigned Patent ALEXANDRIA, Va., March 20 -- Applied Biosystems, Carlsbad, Calif., has been assigned a patent (7,897,738) developed by John Brandis, Austin, Texas, Curtis Bloom, Alta Loma, Calif., and John H. Richards, Bradbury, Calif., for "DNA polymerases having improved labeled nucleotide incorporation properties." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present teachings relate to DNA polymerases that have an F667Y mutation as defined with respect to Taq DNA polymerase and exhibit reduced discrimination against labeled nucleotides into polynucleotides.The teachings also include kits comprising the subject DNA polymerases and numerous methods of using the subject DNA polymerases, including uses for chain termination sequencing and PCR.The present teachings relate to DNA polymerases that have an F667Y mutation as defined with respect to Taq DNA polymerase and exhibit reduced discrimination against labeled nucleotides into polynucleotides. The teachings also include kits comprising the subject DNA polymerases and numerous methods of using the subject DNA polymerases, including uses for chain termination sequencing and PCR." The patent application was filed on Dec. 9, 2005 (11/299,124). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=432&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=9&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** University of California Assigned Patent for Agents and Methods for Enhancing Bone Formation ALEXANDRIA, Va., March 20 -- The University of California, Oakland, Calif., has been assigned a patent (7,897,588) developed by Farhad Parhami, Los Angeles, for "agents and methods for enhancing bone formation." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention discloses agents and methods for inducing osteoblastic cellular differentiation, as well as the use of such agents and method to treat patients to maintain bone mass, enhance bone formation and/or bone repair. Exemplary agents include oxysterols, alone or in combination with particular oxysterols, or other agents known to assist in bone formation. The invention further includes medicaments including oxysterols for the treatment of bone disorders, local injections of oxysterols or cells (206) and implants (202) having agents or cells (203) to facilitate bone repair." The patent application was filed on Aug. 28, 2003 (10/524,945). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=441&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=9&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** Isis Pharmaceuticals Assigned Patent for Oligonucleotide Compositions and Methods for the Modulation of the Expression ALEXANDRIA, Va., March 20 -- Isis Pharmaceuticals, Carlsbad, Calif., has been assigned a patent (7,897,582) developed by C. Frank Bennett, Carlsbad, Calif., and Susan M Freier, San Diego, for an "oligonucleotide compositions and methods for the modulation of the expression of B7 protein." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Compositions and methods for the treatment of asthma with oligonucleotides which specifically hybridize with nucleic acids encoding B7 proteins." The patent application was filed on May 14, 2007 (11/748,422). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=444&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=9&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** Soane Family Trust Assigned Patent ALEXANDRIA, Va., March 20 -- Soane Family Trust, Piedmont, Calif., has been assigned a patent (7,897,563) developed by David S. Soane, Chestnut Hill, Mass., and Daniel J. Suich, Oakland, Calif., for "use of oligomers and polymers for drug solubilization, stabilization, and delivery." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention relates to the use of oligomers and polymers capable of rendering insoluble drugs soluble, protecting unstable drugs, and facilitating the delivery of drugs to their site of action. This invention further relates to processes for the preparation of such oligomers and polymers, and to compositions containing them. In some instances, oligomers, polymers, and/or mixtures thereof can be used to protect a protein drug. Such structures can include at least one recognition element covalently attached to a hydrophilic element, wherein said recognition element or elements interact noncovalently with the protein drug to form a complex in which said protein drug is protected from degradation, recognition by the immune system, and/or renal excretion." The patent application was filed on Dec. 18, 2008 (12/337,991). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=446&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=9&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** Leland Stanford Junior University Assigned Patent ALEXANDRIA, Va., March 20 -- Leland Stanford Junior University, Palo Alto, Calif., has been assigned a patent (7,897,747) developed by Michael Mindrinos, Menlo Park, Calif., Sujatha Krishnakumar, Cupertino, Calif., and Ronald W. Davis, Palo Alto, Calif., for a "method to produce single stranded DNA of defined length and sequence and DNA probes produced thereby." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method for producing a single stranded DNA (ssDNA) molecule of a defined length and sequence is disclosed. This method enables the preparation of, inter alia, probes of greater length than can be chemically synthesized. The method starts with a double stranded molecule, such as genomic, double stranded DNA (dsDNA) from any organism. A fragment of the starting molecule (dsDNA) is amplified by specific primers engineered to introduce cleavage sites on either side of the desired sequence. Cleavage steps on the amplified, engineered fragment are combined with a phosphate removal step, thereby creating a construct that can be digested with an exonuclease without damage to the desired ssDNA. Probes, which hybridize with large gaps between the ends of the probes, are also disclosed." The patent application was filed on May 24, 2007 (11/805,676). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=429&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=9&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** Amgen Assigned Patent for Heterocyclic Modulators of PKB ALEXANDRIA, Va., March 20 -- Amgen, Thousand Oaks, Calif., has been assigned a patent (7,897,619) developed by 13 co-inventors for a "heterocyclic modulators of PKB." The co-inventors are Qingping Zeng, Thousand Oaks, Calif., Dawei Zhang, Thousand Oaks, Calif., Guomin Yao, Newbury Park, Calif., George E. Wohlhieter, Lake Balboa, Calif., Xianghong Wang, Moorpark, Calif., James Rider, Woodland Hills, Calif., Andreas Reichelt, Moorpark, Calif., Holger Monenschein, Camarillo, Calif., Fang-Tsao Hong, Thousand Oaks, Calif., James R. Falsey, Moorpark, Calif., Celia Dominguez, Los Angeles, Matthew P. Bourbeau, Woodland Hills, Calif., and John G. Allen, Newbury Park, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention relates to heterocyclic compounds of Formula I and compositions thereof useful for treating diseases mediated by protein kinase B (PKB) where the variables have the definitions provided herein. ##STR00001## The invention also relates to the therapeutic use of such compounds and compositions thereof in treating disease states associated with abnormal cell growth, cancer, inflammation, and metabolic disorders." The patent application was filed on July 16, 2008 (12/218,754). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=439&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=9&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** GP Medical, National Tsing Hua University Assigned Patent ALEXANDRIA, Va., March 20 -- GP Medical, Newport Beach, Calif., and National Tsing Hua University, Hsinchu, Taiwan, have been assigned a patent (7,897,585) developed by Hsing-Wen Sung, Hsinchu, Taiwan, and Hosheng Tu, Newport Beach, Calif., for "nanoparticles for protein drug delivery." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention discloses the nanoparticles composed of chitosan, poly-glutamic acid, and at least one anti-hemophilic factor or bioactive agent characterized with a positive surface charge and their enhanced permeability in oral drug delivery." The patent application was filed on Feb. 20, 2009 (12/378,976). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=442&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=9&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** SciClone Pharmaceuticals Assigned Patent ALEXANDRIA, Va., March 20 -- SciClone Pharmaceuticals, Foster City, Calif., has been assigned a patent (7,897,567) developed by Alfred R. Rudolph, Los Altos Hills, Calif., and Cynthia W. Tuthill, Menlo Park, Calif., for "methods of protecting against radiation damage using alpha thymosin." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Damage to cells and/or a subject caused by radiation is treated or prevented by administration of an alpha thymosin peptide." The patent application was filed on Nov. 25, 2003 (10/535,835). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=445&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=9&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** Newport Fab Assigned Patent ALEXANDRIA, Va., March 20 -- Newport Fab, Newport Beach, Calif., has been assigned a patent (7,897,484) developed by Arjun Kar-Roy, Irvine, Calif., Marco Racanelli, Santa Ana, Calif., and David J. Howard, Irvine, Calif., for a "fabricating a top conductive layer in a semiconductor die." The abstract of the patent published by the U.S. Patent and Trademark Office states: "According to an exemplary embodiment, a method for fabricating a top conductive layer in a semiconductor die includes forming a through-wafer via opening through at least one interlayer dielectric layer in a through-wafer via region of the semiconductor die. The method further includes extending the through-wafer via opening through a substrate of the semiconductor die to reach a target depth. The method further includes forming a through-wafer via conductive layer in the through-wafer via opening, and concurrently forming the top conductive layer over an exposed top metal segment." The patent application was filed on Aug. 3, 2009 (12/462,436). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=454&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=10&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** SanDisk 3D Assigned Patent ALEXANDRIA, Va., March 20 -- SanDisk 3D, Milpitas, Calif., has been assigned a patent (7,897,453) developed by five co-inventors for a "dual insulating layer diode with asymmetric interface state and method of fabrication." The co-inventors are Xiying Chen, San Jose, Calif., Deepak Chandra Sekar, Sunnyvale, Calif., Mark Clark, Santa Clara, Calif., Dat Nguyen, San Jose, Calif., and Tanmay Kumar, Pleasanton, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "An integrated circuit including vertically oriented diode structures between conductors and methods of fabricating the same are provided. The diode is a metal-insulator diode having a first metal layer, a first insulating layer, a second insulating layer and a second metal layer. At least one asymmetric interface state is provided at the intersection of at least two of the layers to increase the ratio of the diode's on-current to its reverse bias leakage current. In various examples, the asymmetric interface state is formed by a positive or negative sheet charge that alters the barrier height and/or electric field at one or more portions of the diode. Two-terminal devices such as passive element memory cells can utilize the diode as a steering element in series with a state change element. The devices can be formed using pillar structures at the intersections of upper and lower conductors." The patent application was filed on Dec. 16, 2008 (12/336,410). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=457&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=10&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** Sirna Therapeutics Assigned Patent for RNA Interference Mediated Inhibition of XIAP Gene Expression Using Short ALEXANDRIA, Va., March 20 -- Sirna Therapeutics, San Francisco, has been assigned a patent (7,897,753) developed by James McSwiggen, Boulder, Colo., and Leonid Beigelman, Brisbane, Calif., for a "RNA interference mediated inhibition of XIAP gene expression using short interfering nucleic acid (siNA)." The abstract of the patent published by the U.S. Patent and Trademark Office states: "This invention relates to compounds, compositions, and methods useful for modulating XIAP gene expression using short interfering nucleic acid (siNA) molecules. This invention also relates to compounds, compositions, and methods useful for modulating the expression and activity of other genes involved in pathways of XIAP gene expression and/or activity by RNA interference (RNAi) using small nucleic acid molecules. In particular, the instant invention features small nucleic acid molecules, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double stranded RNA (dsRNA), micro-RNA (miRNA), and short hairpin RNA (shRNA) molecules and methods used to modulate the expression of XIAP genes." The patent application was filed on Sept. 5, 2008 (12/205,113). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=426&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=9&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** Applied Materials Assigned Patent ALEXANDRIA, Va., March 20 -- Applied Materials, Santa Clara, Calif., has been assigned a patent (7,897,495) developed by Zhiyuan Ye, San Jose, Calif., Andrew M. Lam, San Francisco, and Yihwan Kim, Milpitas, Calif., for a "formation of epitaxial layer containing silicon and carbon." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Methods for formation of epitaxial layers containing silicon are disclosed. Specific embodiments pertain to the formation and treatment of epitaxial layers in semiconductor devices, for example, Metal Oxide Semiconductor Field Effect Transistor (MOSFET) devices. In specific embodiments, the formation of the epitaxial layer involves exposing a substrate in a process chamber to deposition gases including two or more silicon source such as silane and a higher order silane. Embodiments include flowing dopant source such as a phosphorus dopant, during formation of the epitaxial layer, and continuing the deposition with the silicon source gas without the phosphorus dopant." The patent application was filed on Dec. 12, 2006 (11/609,608). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=451&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=10&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** National Semiconductor Assigned Patent ALEXANDRIA, Va., March 20 -- National Semiconductor, Santa Clara, Calif., has been assigned a patent (7,897,472) developed by four co-inventors for an "apparatus and method for wafer level fabrication of high value inductors on semiconductor integrated circuits." The co-inventors are Peter J. Hopper, San Jose, Calif., Peter Johnson, Sunnyvale, Calif., Kyuwoon Hwang, Palo Alto, Calif., and Andrei Papou, San Jose, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Methods for forming multiple inductors on a semiconductor wafer are described. A plating layer and a photoresist layer are applied over a semiconductor wafer. Recess regions are etched in the photoresist layer using photolithographic techniques, which exposes portions of the underlying plating layer. Metal is electroplated into the recess regions in the photoresist layer to form multiple magnetic core inductor members. A dielectric insulating layer is applied over the magnetic core inductor members. Additional plating and photoresist layers are applied over the dielectric insulating layer. Recess regions are formed in the newly applied photoresist layer. Electroplating is used to form inductor windings in the recess regions. Optionally, a magnetic paste can be applied over the inductor coils." The patent application was filed on Nov. 23, 2009 (12/624,259). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=456&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=10&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** Sirna Therapeutics Assigned Patent for RNA Interference Mediated Inhibition of Telomerase Gene Expression Using Short ALEXANDRIA, Va., March 20 -- Sirna Therapeutics, San Francisco, has been assigned a patent (7,897,752) developed by James McSwiggen, Boulder, Colo., and Leonid Beigelman, Brisbane, Calif., for a "RNA interference mediated inhibition of telomerase gene expression using short interfering nucleic acid (siNA)." The abstract of the patent published by the U.S. Patent and Trademark Office states: "This invention relates to compounds, compositions, and methods useful for modulating telomerase gene expression using short interfering nucleic acid (siNA) molecules. This invention also relates to compounds, compositions, and methods useful for modulating the expression and activity of other genes involved in pathways of telomerase gene expression and/or activity by RNA interference (RNAi) using small nucleic acid molecules. In particular, the instant invention features small nucleic acid molecules, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA), and short hairpin RNA (shRNA) molecules and methods used to modulate the expression of telomerase genes, such as telomerase template RNA (TERC/TR), or a telomerase protein (TERT)." The patent application was filed on July 9, 2008 (12/170,310). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=427&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=9&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** University of California Assigned Patent for Operation of a Steam Methane Reformer by Direct Feeding ALEXANDRIA, Va., March 20 -- The University of California, Oakland, Calif., has been assigned a patent (7,897,649) developed by Joseph M. Norbeck, Riverside, Calif., and Chan Seung Park, Placentia, Calif., for an "operation of a steam methane reformer by direct feeding of steam rich producer gas from steam hydro-gasification." The abstract of the patent published by the U.S. Patent and Trademark Office states: "An improved, economical alternative method to supply steam and methane to a steam methane reformer (SMR) is accomplished by a combination of procedures, wherein product gas from a steam hydro-gasification reactor (SHR) is used as the feedstock for the SMR by removing impurities from the product stream from the SHR with a gas cleanup unit that operates substantially at process pressures and at a temperature above the boiling point of water at the process pressure, is located between the SHR and SMR." The patent application was filed on July 16, 2007 (11/879,266). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=435&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=9&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** iTherX Pharmaceuticals Assigned Patent ALEXANDRIA, Va., March 20 -- iTherX Pharmaceuticals, San Diego, has been assigned a patent (7,897,599) developed by 14 co-inventors for cytokine inhibitors. The co-inventors are Erik Boman, Chula Vista, Calif., Susana Conde Ceide, San Diego, Russell Dahl, Carlsbad, Calif., Nancy G. J. Delaet, San Diego, Justin Ernst, San Diego, Antonio Garrido Montalban, San Diego, Jeffrey Kahl, San Diego, Christopher Larson, San Diego, Stephen Miller, San Diego, Hiroshi Nakanishi, San Diego, Edward Roberts, Fallbrook, Calif., Eddine Saiah, La Jolla, Calif., Robert Sullivan, Vista, Calif., and Zhinjun Wang, San Diego.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention provides low molecular weight compounds useful as cytokine inhibitors, and compositions thereof. In particular, compounds of the invention are useful as anti-inflammatory agents. There are further provided methods for the preparation of such agents and their use in preventing or treating conditions mediated by cytokines such as arthritis." The patent application was filed on Dec. 14, 2009 (12/637,714). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=440&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=9&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** Northrop Grumman Systems Assigned Patent ALEXANDRIA, Va., March 20 -- Northrop Grumman Systems, Los Angeles, has been assigned a patent (7,897,446) developed by six co-inventors for a "method of forming a high electron mobility transistor hemt, utilizing self-aligned miniature field mitigating plate and protective dielectric layer." The co-inventors are Ioulia Smorchkova, Lakewood, Calif., Robert Coffie, Camarillo, Calif., Ben Heying, Fullerton, Calif., Carol Namba, Walnut, Calif., Po-Hsin Liu, Anaheim, Calif., and Boris Hikin, Los Angeles.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A semiconductor device is fabricated to include source and drain contacts including an ohmic metal sunken into the barrier layer and a portion of the channel layer; a protective dielectric layer disposed between the source and drain contacts on the barrier layer; a metallization layer disposed in drain and source ohmic vias between the source contact and the protective dielectric layer and between the protective dielectric layer and the drain contact; and a metal T-gate disposed above the barrier layer including a field mitigating plate disposed on a side portion of a stem of the metal T-gate." The patent application was filed on March 25, 2010 (12/659,910). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=458&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=10&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** Complete Genomics Assigned Patent ALEXANDRIA, Va., March 20 -- Complete Genomics, Mountain View, Calif., has been assigned a patent (7,897,344) developed by Fredrik Dahl, Menlo Park, Calif., Radoje Drmanac, Los Altos Hills, Calif., and Andrew Sparks, Los Gatos, Calif., for "methods and oligonucleotide designs for insertion of multiple adaptors into library constructs." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Aspects described and claimed herein provide methods to insert multiple DNA adaptors into a population of circular target DNAs at defined positions and orientations with respect to one another. The resulting multi-adaptor constructs are then used in massively-parallel nucleic acid sequencing techniques." The patent application was filed on Nov. 6, 2008 (12/266,385). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=474&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=10&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** Applied Biosystems Assigned Patent ALEXANDRIA, Va., March 20 -- Applied Biosystems, Carlsbad, Calif., has been assigned a patent (7,897,338) developed by Sam Lee Woo, Redwood City, Calif., Ronald J. Graham, San Ramon, Calif., and Jing Tian, Mountain View, Calif., for "mobility-modified nucleobase polymers and methods of using same." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates generally to nucleobase polymer functionalizing reagents, to mobility-modified sequence-specific nucleobase polymers, to compositions comprising a plurality of mobility-modified sequence-specific nucleobase polymers, and to the use of such polymers and compositions in a variety of assays, such as, for example, for the detection of a plurality of selected nucleotide sequences within one or more target nucleic acids. The mobility-modifying polymers of the present invention include phosphoramidite reagents which can be joined to other mobility-modifying monomers and to sequence-specific oligonucleobase polymers via uncharged phosphate triester linkages. Addition of the mobility-modifying phosphoramidite reagents of the present invention to oligonucleobase polymers results in unexpectedly large effects the mobility of those modified oligonucleobase polymers, especially upon capillary electrophoresis in non-sieving media." The patent application was filed on July 11, 2006 (11/456,836). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=475&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=10&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** Clear Focus Imaging Assigned Patent ALEXANDRIA, Va., March 20 -- Clear Focus Imaging, Santa Rosa, Calif., has been assigned a patent (7,897,230) developed by Gregory Ross, Santa Rosa, Calif., for "one-way vision display panels with retention layer." The abstract of the patent published by the U.S. Patent and Trademark Office states: "One or more types of ink retention layers for a one-way vision display panel and methods are provided. In one example, a one-way vision display panel assembly includes a perforated panel formed of a flexible material. The perforated panel having a front surface, a rear surface and a plurality of through holes extending from the front surface to the rear surface. An ink retention layer is located adjacent to the perforated panel. The ink retention layer includes material that retains or absorbs residual ink from an image applied to the front surface of the perforated panel. The one-way vision display panel may further include a releasing layer or a backing layer, or both." The patent application was filed on April 30, 2007 (11/790,972). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=479&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=10&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** Applied Materials Assigned Patent for Low Temperature ALD SiO.Sub.2 ALEXANDRIA, Va., March 20 -- Applied Materials, Santa Clara, Calif., has been assigned a patent (7,897,208) developed by Maitreyee Mahajani, Saratoga, Calif., Yi-Chiau Huang, Fremont, Calif., and Brendan McDougall, Livermore, Calif., for a "low temperature ALD SiO.sub.2." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention generally comprises a silicon dioxide atomic layer deposition method. By providing pyridine as a catalyst, water may be utilized as the oxidization source while depositing at a low temperature. Prior to exposing the substrate to the water, the substrate may be exposed to a pyridine soak process. Additionally, the water may be co-flowed to the chamber with the pyridine through separate conduits to reduce interaction prior to entering the chamber. Alternatively, the pyridine may be co-flowed with a silicon precursor that does not react with pyridine." The patent application was filed on May 26, 2010 (12/788,131). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=482&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=10&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** FormFactor Assigned Patent ALEXANDRIA, Va., March 20 -- FormFactor, Livermore, Calif., has been assigned a patent (7,897,435) developed by Benjamin N. Eldridge, Danville, Calif., and Gaetan L. Mathieu, Varennes, Canada, for a "re-assembly process for MEMS structures." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Methods of fabricating an array of aligned microstructures on a substrate are disclosed. The microstructures may be spring contacts or other microelements. The methods disclosed include construction of an alignment substrate, alignment of die elements with the alignment substrate, and fixation of the aligned die elements to a backing substrate." The patent application was filed on May 25, 2006 (11/420,403). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=462&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=10&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** LAM Research Assigned Patent ALEXANDRIA, Va., March 20 -- LAM Research, Fremont, Calif., has been assigned a patent (7,897,213) developed by six co-inventors for "methods for contained chemical surface treatment." The co-inventors are Katrina Mikhaylichenko, San Jose, Calif., Mike Ravkin, Sunnyvale, Calif., Fritz Redeker, Fremont, Calif., John M. de Larios, Palo Alto, Calif., Erik M. Freer, Campbell, Calif., and Mikhail Korolik, San Jose, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "An apparatus, system and method for preparing a surface of a substrate using a proximity head includes applying a non-Newtonian fluid between the surface of the substrate and a head surface of the proximity head. The non-Newtonian fluid defines a containment wall along one or more sides between the head surface and the surface of the substrate. The one or more sides provided with the non-Newtonian fluid define a treatment region on the substrate between the head surface and the surface of the substrate. A Newtonian fluid is applied to the surface of the substrate through the proximity head, such that the applied Newtonian fluid is substantially contained in the treatment region defined by the containment wall. The contained Newtonian fluid aids in the removal of one or more contaminants from the surface of the substrate. In one example, the non-Newtonian fluid can also be used to create ambient controlled isolated regions, which can assist in controlled processing of surfaces within the regions. In an alternate example, a second non-Newtonian fluid is applied to the treatment region instead of the Newtonian fluid. The second non-Newtonian fluid acts on one or more contaminants on the surface of the substrate substantially removing them from the surface of the substrate." The patent application was filed on Feb. 8, 2007 (11/704,435). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=481&f=G&l=50&d=PTXT&s1=20110301.PD.&s2=%28CA.ASST.%29&co1=AND&p=10&OS=ISD/03/01/2011+AND+AS/CA&RS=ISD/03/01/2011+AND+AS/CA Written by Satyaban Rath; edited by Hemanta Panigrahi, in collaboration with Contify.

*** Synthasome Assigned Patent for Method and Material for Enhanced Tissue-Biomaterial Integration ALEXANDRIA, Va., March 20 -- Synthasome, San Diego, has been assigned a patent (7,897,165) developed by Jennifer Elisseeff, Baltimore, Dong-an Wang, Baltimore, and Anthony Ratcliffe, Del Mar, Calif., for a "method and material for enhanced tissue-biomaterial integration." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to the covalent binding of a hydrogel to an extracellular matrix (ECM). The integration of the hydrogel with the tissue is superior to that in previous techniques. Moreover, unlike previous techniques, the present invention does not require a photoinitiator. Potential therapeutic applications inclu For more information about Targeted News Service products and services, please contact: Myron Struck, editor, Targeted News Service LLC, Springfield, Va., 703/304-1897; editor@targetednews.com; http://targetednews.com.

-1042030 (c) 2011 Targeted News Service

[ Back To WebRTC Solutions's Homepage ]

FOLLOW US

Featured Podcasts

Oracle in Enterprise Communications

Most in the industry have heard of the acquisition of Acme Packet by Oracle. What you may not know is that Oracle has a number of telecommunications products including a UC suite, WebRTC Session Controller, and Operations monitoring tools. Oracle is pursuing both the enterprise and service provider.

Featured Whitepapers

WebRTC Security Concerns

This whitepaper covers two of the most relevant topics in communications industry today: WebRTC and security. We will introduce the problem of security in WebRTC including those traditional VoIP attacks that are going to be present in WebRTC services. Later we will mention ad-hoc WebRTC attacks and protection mechanisms, to close with an overview of identity management solutions.

Migrating Real Time Communications Services to the Web

In the Internet age, businesses that own fixed and mobile communication networks, including traditional Communications Service Providers (CSPs) of all kinds, are being challenged with some tough questions: How do we stay relevant to our customers?

Delivering Enterprise-Class Communications with WebRTC

WebRTC is an emerging industry standard for enabling Web browsers with real-time communications capabilities. It enables enterprises to enhance Web sites, empower BYOD users, and improve video collaboration and on-line meetings, to name but a few examples.

WebRTC Report Extract Reprint

This document examines the growing important of WebRTC, both generally and for telecom service providers. It considers the expanding range of use-cases, the multiple layers of interoperability likely to be desired by telcos, and some implications in terms of network integration and mobility.

WEBRTC SOLUTIONS PAPERS, SLIDES, COLLATERAL

Robust Enterprise Grade WebRTC Systems and Services


The emerging WebRTC standard has become one of the industry's hottest topics – and with good reason. Being able to "communications enable the web" has Communications Service Providers as well as Enterprises busily making plans for deployment. But, as these plans unfold, reality is starting to intrude on those plans. Our expectations of telephony services are much higher than web browsing. We expect the phone to connect instantly, operate with minimal disruption, and work seamless across any network, anywhere, at any time. There is also an understanding that phone service is inherently secure. With WebRTC, the expectation is for these applications to behave in the same manner.

This session looks at the user experience and expectations of a WebRTC Enterprise service. It will also cover how a WebRTC enterprise handles security, reliability, and interoperability within browsers and networks.

ORACLE COMMUNICATIONS WEBRTC SESSION CONTROLLER

The Oracle Communications WebRTC Session Controller enables communications service providers (CSPs) and enterprises to offer WebRTC services – from virtually any device, across virtually any network – with carrier-grade reliability and security.

Sales Presentation: Oracle Communications WebRTC Session Controller

Agenda:
- WebRTC Market and Opportunities
- WebRTC Challenges
- Oracle Communication WebRTC Session   Controller
- Summary

ORACLE COMMUNICATIONS WEBRTC SESSION CONTROLLER SOLUTION

Communication Service Provider (CSP) voice service revenues continue to face pressure due to shifts in communication preferences and competition from non-traditional service providers. Voice communications are now often embedded into applications outside the domain of traditional telephony voice usage. CSPs have been challenged to effectively leverage and monetize new web-oriented communications technologies.